news - International Biopharmaceutical Industry

Current Edition

news

Cellmid inks deal with China’s Fukangren Bio-pharm

The deal aims to distribute Cellmid's évolis and anti-aging hair care products in the Peoples Republic of China Australia based Cellmid has recently announced that ...

4 May 2018 news Bio-pharm | Cellmid

Continue Reading →

news

Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support...

4 May 2018 news common | Haselmeier

Continue Reading →

news

Q1 earnings preview: Novo, Celgene still to come

It hasn't been the prettiest first quarter for drugmakers. Sanofi's revenue fell, as did confidence in one of the company's key growth drivers. Allergan discussed a s...

3 May 2018 news

Continue Reading →

news

For Expensive New Drugs, Biopharma Should Make Money-Back Guarantees Mandatory

In a recent paper on “Value-Based Pricing for Drugs”, authors Anna Kaltenboeck and Peter B. Bach of the Memorial Sloan Kettering Cancer Center discuss the high cost o...

3 May 2018 news biopharma | Drugs

Continue Reading →

news

ExpreS2ion’s U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product

ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its U.S.-based partner and licensee Integrated BioTherapeutics (“IBT”) has initiated sales and marketin...

2 May 2018 news biotherapeutics | Expres2ion

Continue Reading →

news

Saunders: All options remain on the table for Allergan

Brief: Allergan CEO Brent Saunders said Monday the Irish pharma is considering a wide range of business options, including further divestitures or a split of the ...

1 May 2018 news Allergan | CEO

Continue Reading →

news

United Therapeutics nabs competing PAH drug with $216M SteadyMed buy

Brief: United Therapeutics announced Monday morning that it will acquire competitor SteadyMed for $4.46 per share in cash upfront and another $2.63 per share in c...

1 May 2018 news 216 | Drug

Continue Reading →

news

Sparks sells regulatory fast pass to Jazz for $110M

Brief: Spark Therapeutics has sold a priority review voucher (PRV) to Jazz Pharmaceuticals for $110 million, according to a Monday disclosure. While details wer...

1 May 2018 news 110 | fastpass

Continue Reading →

news

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16th May at 2:30PM, at the National Conference Centre in ...

1 May 2018 news

Continue Reading →

news

Pfizer Receives CRL for Biosimilar to Roche’s Herceptin

On April 23, 2018, Pfizer announced that it received a complete response letter (CRL) from FDA in response to the biologics license application (BLA) for the company’...

1 May 2018 news Biosimilar | CRL

Continue Reading →